Form 4: Bluebird Bio Chief Medical Officer Sells Shares to Cover Tax Obligations

Bluebird Bio's Chief Medical Officer, Richard A. Colvin, sold 2,824 shares of common stock at $0.4173 per share to cover tax obligations related to vesting restricted stock units.

Summary

• Richard A. Colvin, the Chief Medical Officer of bluebird bio, Inc., sold 2,824 shares of common stock on December 10, 2024.
• The sale was executed at a price of $0.4173 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Colvin directly owns 165,544 shares of bluebird bio common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the biotechnology industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar transactions by executives at other firms.
• The sale of 2,824 shares is relatively small compared to the total shares held by the executive, which is typical for these types of transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by an executive for tax purposes.

Key Dates

Keywords

bluebird bio, Richard A. Colvin, stock sale, insider trading, tax obligations, restricted stock units, share transaction